Physician profile

Jill Bressler

Neurology (Psychiatry & Neurology) · Syosset, NY

NPI 1306894217

$6,978.64

in general payments reported to CMS, 2019-2025

41 companies · $497 in 2025

The $497 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).

See the full distribution for Neurology (Psychiatry & Neurology)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,154.89
Education$189.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,665.21 2021-2025 Qulipta, Ubrelvy, Botox
Allergan, INC. $1,292.02 2019-2020
Biogen, INC. $588.93 2019-2025 Vumerity, Plegridy, Tysabri
Lundbeck LLC $490.09 2021-2025 Vyepti
Jazz Pharmaceuticals INC. $393.74 2020-2024
Medtronic, INC. $213.30 2022-2024 Prestige LP Cervical Disc System, Percept PC Brainsense
Neurelis, INC. $199.46 2022-2023 Valtoco
Eisai INC. $192.80 2019-2025
Scilex Pharmaceuticals INC. $177.42 2019-2024
Lilly USA, LLC $132.82 2019-2023 Emgality, Reyvow
Ucb, INC. $130.68 2019-2022
Acorda Therapeutics, INC $125.23 2019-2022
Amgen INC. $99.68 2019-2022
Tanabe Pharma America, INC. $96.32 2022-2023
Corium, LLC $95.11 2022-2023 Adlarity
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Impel Pharmaceuticals INC. $93.88 2022-2023 Trudhesa
Celgene Corporation $89.15 2024-2025 Zeposia
Teva Pharmaceuticals USA, INC. $74.80 2019-2020
Avanir Pharmaceuticals, INC. $69.90 2019
Sk Life Science, INC. $68.48 2021
Greenwich Biosciences, INC. $66.89 2019-2020
Genzyme Corporation $64.86 2021-2022
Zyla Life Sciences, INC. $64.58 2019
Biohaven Pharmaceutical Holding Company LTD. $55.36 2022
Amylyx Pharmaceuticals, INC. $51.39 2023-2024 Relyvrio
Biohaven Pharmaceuticals, INC. $45.43 2021
Ibsa Pharma INC. $43.03 2022-2023 Tirosint, Licart
Supernus Pharmaceuticals, INC. $42.64 2019-2020
Alexion Pharmaceuticals, INC. $36.80 2019-2020
Grifols USA, LLC $32.24 2019-2023 Gamunex-C
Alnylam Pharmaceuticals INC. $24.94 2019
Otsuka America Pharmaceutical, INC. $23.21 2024 Nuedexta
Arbor Pharmaceuticals, INC. $20.48 2021
Amneal Pharmaceuticals LLC $18.84 2021
Currax Pharmaceuticals LLC $17.33 2021
Boston Scientific Corporation $15.51 2019
Pfizer INC. $13.97 2023
Upsher-Smith Laboratories LLC $13.41 2021
Ge Healthcare $13.38 2019
Csl Behring $13.04 2021
Abbott Laboratories $12.29 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jill Bressler

$6,978.64

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $497 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).

https://glasscript.com/doctor/1298437/jill-bressler

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.